MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
PLoS One. 2011;6(8):e22726. doi: 10.1371/journal.pone.0022726. Epub 2011 Aug 11.
CD1d is a MHC I like molecule which presents glycolipid to natural killer T (NKT) cells, a group of cells with diverse but critical immune regulatory functions in the immune system. These cells are required for optimal defence against bacterial, viral, protozoan, and fungal infections, and control of immune-pathology and autoimmune diseases. CD1d is expressed on antigen presenting cells but also found on some non-haematopoietic cells. However, it has not been observed on bronchial epithelium, a site of active host defence in the lungs. Here, we identify for the first time, CD1D mRNA variants and CD1d protein expression on human bronchial epithelial cells, describe six alternatively spliced transcripts of this gene in these cells; and show that these variants are specific to epithelial cells. These findings provide the basis for investigations into a role for CD1d in lung mucosal immunity.
CD1d 是一种 MHC I 样分子,它将糖脂递呈给自然杀伤 T(NKT)细胞,NKT 细胞是免疫系统中具有多种但关键免疫调节功能的细胞群。这些细胞对于最佳防御细菌、病毒、原生动物和真菌感染以及控制免疫病理学和自身免疫性疾病是必需的。CD1d 表达于抗原呈递细胞上,但也存在于一些非造血细胞上。然而,在肺部活跃宿主防御的部位——支气管上皮细胞上,尚未观察到 CD1d。在这里,我们首次在人支气管上皮细胞上鉴定出 CD1D mRNA 变体和 CD1d 蛋白表达,描述了该基因在这些细胞中的六种选择性剪接转录本;并表明这些变体是上皮细胞特有的。这些发现为研究 CD1d 在肺黏膜免疫中的作用提供了基础。